Skip to main content

Addressing the Three Most Frequently Asked Questions of a Bioethicist in an Oncofertility Setting

  • Chapter
  • First Online:
Oncofertility Medical Practice

Abstract

Many ethical issues surround the provision of fertility preservation for patients diagnosed with cancer. Three of the most common questions—who should be offered or undergo fertility preservation procedures, who should pay for those procedures, and the ownership of the resulting banked reproductive materials—are discussed in detail in this chapter. Patient age, marital status, and prognosis are important issues that must be considered when determining who should undergo fertility preservation procedures. A case is made for insurance coverage of fertility preservation for cancer patients, as infertility is a consequence of cancer treatment. Finally, the complex legal issues with regard to ownership of gametes (eggs, sperm), embryos, and gonadal tissue that are banked as a result of fertility preservation procedures are discussed, as well as approaches to preventing disputes over reproductive material, such as the use of advance directives. Clinicians will need to anticipate these ethical issues and their patients’ questions and consider each patient’s individual needs and circumstances in order to provide appropriate care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Woodruff TK. The Oncofertility Consortium—addressing fertility in young people with cancer. Nat Rev Clin Oncol. 2010;7:466–75.

    Article  PubMed  Google Scholar 

  2. Dunson DB, Baird DD, Colombo B. Increased infertility with age in men and women. Obstet Gynecol. 2004;103:51–6.

    Article  PubMed  Google Scholar 

  3. Committee on Gynecologic Practice of American College of Obstetricians and Gynecologists; Practice Committee of American Society for Reproductive Medicine. Age-related fertility decline: a committee opinion. Fertil Steril. 2008;90:S154–5.

    Google Scholar 

  4. Garrido N, et al. Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to measuring the likelihood of IVF success. Fertil Steril. 2011;96:40–6.

    Article  PubMed  Google Scholar 

  5. Caplan AL, Patrizio P. Are you ever too old to have a baby? The ethical challenges of older women using infertility services. Semin Reprod Med. 2010;28:281–6.

    Article  PubMed  Google Scholar 

  6. Maltaris T, et al. Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol. 2006;103:1109–21.

    Article  PubMed  Google Scholar 

  7. Quinn GP, et al. Frozen hope: fertility preservation for women with cancer. J Midwifery Womens Health. 2010;55:175–80.

    Article  PubMed  Google Scholar 

  8. Robinson BE. Birds do it. Bees do it. So why not single women and lesbians? Bioethics. 1997;11:217–27.

    Article  PubMed  Google Scholar 

  9. Basco D, Campo-Engelstein L, Rodriguez S. Insuring against infertility: expanding state infertility mandates to include fertility preservation technology for cancer patients. J Law Med Ethics. 2010;38:832–9.

    Article  PubMed  Google Scholar 

  10. Campo-Engelstein L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J Clin Oncol. 2010;28:1284–6.

    Article  PubMed  Google Scholar 

  11. Campo-Engelstein L. For the sake of consistency and fairness: why insurance companies should cover fertility preservation treatment for iatrogenic infertility. Cancer Treat Res. 2010;156:381–8.

    Article  PubMed  Google Scholar 

  12. Fertile Hope. Financial assistance. 2011. http://www.fertilehope.org/financial-assistance/index.cfm. Accessed 2 Aug 2011.

  13. Smith K. Cost of fertility preservation treatment at Northwestern University, Campo-Engelstein L, editor. 2011 (Personal communication).

    Google Scholar 

  14. Chambers GM, et al. The economic impact of assisted reproductive technology: a review of selected developed countries. Fertil Steril. 2009;91:2281–94.

    Article  PubMed  Google Scholar 

  15. Elster NR. Assisted reproductive technologies: contracts, consents, and controversies. Am J Fam Law. 2005;18:193–9.

    PubMed  Google Scholar 

  16. Kingdregan CP, Snyder SH. Clarifying the law of ART: the new American Bar Association model act governing assisted reproductive technology. Fam Law Q. 2008;42:203–29.

    Google Scholar 

  17. Fuselier BM. The trouble with putting all of your eggs in one basket: using a property rights model to resolve disputes over cryopreserved pre-embryos. Texas J Civil Lib Civil Rights. 2009;14:143–91.

    Google Scholar 

  18. National Organ Transplantation Act, 42 USC §273 (1984).

    Google Scholar 

  19. Campo-Engelstein L. Gametes or organs? How should we legally classify ovaries used for transplantation in the USA? J Med Ethics. 2011;37:166–70.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Oncofertility Consortium NIH/NICHD 5UL1DE019587.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa Campo-Engelstein Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Campo-Engelstein, L. (2012). Addressing the Three Most Frequently Asked Questions of a Bioethicist in an Oncofertility Setting. In: Gracia, C., Woodruff, T. (eds) Oncofertility Medical Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9425-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9425-7_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9424-0

  • Online ISBN: 978-1-4419-9425-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics